Baxter International BAX Healthcare Systems & Technologies — Cost of Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Baxter International in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Baxter International's healthcare systems & technologies — cost of sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Baxter International's healthcare systems & technologies — cost of sales?
- Baxter International (BAX) reported healthcare systems & technologies — cost of sales of $390M in Q1 2026.
- How has Baxter International's healthcare systems & technologies — cost of sales changed year-over-year?
- Baxter International's healthcare systems & technologies — cost of sales increased by 9.6% year-over-year, from $356M to $390M.
- What is the long-term trend for Baxter International's healthcare systems & technologies — cost of sales?
- Over 3 years (2022 to 2025), Baxter International's healthcare systems & technologies — cost of sales has grown at a 3.1% compound annual growth rate (CAGR), from $1.46B to $1.6B.
- What does healthcare systems & technologies — cost of sales mean?
- The direct costs incurred to produce and deliver the products sold by this segment.
- How do you interpret healthcare systems & technologies — cost of sales?
- Lower costs relative to sales indicate improved manufacturing efficiency or better supply chain management.
- How does healthcare systems & technologies — cost of sales compare across companies?
- Standard COGS metric used across the medical device industry to measure gross margin performance.